DLX4 and neoplasm: In a xenograft model, Haria et al. found that DLX4, a transcription factor encoded by a homeobox gene, induced expression of CD44 in ovarian tumor cells, and inhibition of CD44 abrogated the ability of DLX4 to stimulate tumor-mesothelial cell interactions [30].